TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
12.20
+0.10 (0.83%)
Feb 11, 2026, 1:30 PM CST

TPEX:4157 Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
38.75150.65123.1336.231,29523.42
Revenue Growth (YoY)
-73.95%22.35%239.87%-97.20%5426.95%15.30%
Cost of Revenue
18.6716.1311.453.7412.724.04
Gross Profit
20.08134.52111.6932.491,28219.39
Selling, General & Admin
75.390.5598.972.6499.0677.27
Research & Development
116.94166.07187.48237.52283.28249.44
Operating Expenses
192.24256.62286.39310.16382.34326.71
Operating Income
-172.16-122.1-174.7-277.67899.46-307.32
Interest Expense
-1.72-1.42-1.14-0.85-0.24-0.6
Interest & Investment Income
21.4424.420.388.724.233.5
Earnings From Equity Investments
-----23.24-113.04
Currency Exchange Gain (Loss)
-36.7354.17-15.6851.79-4.2413.08
Other Non Operating Income (Expenses)
0.430.48149.40.010.04-
EBT Excluding Unusual Items
-188.73-44.47-21.73-218876-404.38
Gain (Loss) on Sale of Investments
7.8313.55165.220.30.080.43
Gain (Loss) on Sale of Assets
-2.29----0.080.01
Asset Writedown
-0.77-1.96--12.06--2.92
Pretax Income
-183.96-32.89143.49-229.77875.99-406.87
Income Tax Expense
0.245.76.767.4100.37-2.06
Net Income
-184.2-38.58136.73-237.16775.62-404.82
Net Income to Common
-184.2-38.58136.73-237.16775.62-404.82
Shares Outstanding (Basic)
717717717717717717
Shares Outstanding (Diluted)
717717717717717717
Shares Change (YoY)
-0.06%0.03%0.06%-0.07%0.07%0.01%
EPS (Basic)
-0.26-0.050.19-0.331.08-0.56
EPS (Diluted)
-0.26-0.050.19-0.331.08-0.56
Free Cash Flow
0.02-173.623.57-24.66618.83-247.56
Free Cash Flow Per Share
--0.240.01-0.030.86-0.34
Gross Margin
51.81%89.29%90.70%89.69%99.02%82.77%
Operating Margin
-444.32%-81.05%-141.88%-766.41%69.48%-1312.10%
Profit Margin
-475.38%-25.61%111.04%-654.61%59.91%-1728.37%
Free Cash Flow Margin
0.06%-115.25%2.90%-68.06%47.80%-1056.95%
EBITDA
-167.37-113.76-164.59-267.53909.9-295.49
EBITDA Margin
--75.51%-133.67%-70.29%-
D&A For EBITDA
4.798.3410.1110.1410.4411.83
EBIT
-172.16-122.1-174.7-277.67899.46-307.32
EBIT Margin
--81.05%-141.88%-69.48%-
Effective Tax Rate
--4.71%-11.46%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.